Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations

Clinical trial NCT06519110 · UNKNOWN

Trial details

NCT number: NCT06519110
Sponsor: Convalife (Shanghai) Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-08-10
Primary completion: 2026-02-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.